HM Payson & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

HM Payson & Co’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	–	–	1111
2022 Q2	$0	Hold	200	–	–	﹤0.01%	1178
2022 Q1	$1K	Buy	+200	New	+$1.71K	﹤0.01%	1039

Other funds holding DBD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

BPCM

Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HM Payson & Co's DBD Position: Q3 2022 in Review

HM Payson & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2022, closing a stake of 200 shares.

HM Payson & Co first reported a position in DBD in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 165 funds tracked by Wall St. Rank hold DBD as of Q3 2022.

HM Payson & Co reported no remaining Diebold Nixdorf Incorporated position as of Q3 2022 after selling out during the quarter.
HM Payson & Co sold 200 Diebold Nixdorf Incorporated shares in Q3 2022.
HM Payson & Co first reported a position in Diebold Nixdorf Incorporated in Q1 2022 and held it in 2 quarters.
HM Payson & Co's Diebold Nixdorf Incorporated position peaked at $1K in Q1 2022.
165 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2022.

Based on HM Payson & Co's 13F filing for Q3 2022, filed 25 Oct 2022.